C12N 2710/16622
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/16622 (New viral proteins or individual genes, new structural or functional aspects of) appears on 544 US grants and 490 published applications in this corpus.
Search patents in C12N- Granted patents
- 544
- Published applications
- 490
- Assignees
- 338
- Inventors
- 1,015
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 8 | 0 |
| 1989 | 7 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 10 | 0 |
| 1993 | 9 | 0 |
| 1994 | 8 | 0 |
| 1995 | 6 | 0 |
| 1996 | 19 | 0 |
| 1997 | 23 | 0 |
| 1998 | 43 | 0 |
| 1999 | 31 | 0 |
| 2000 | 31 | 0 |
| 2001 | 27 | 6 |
| 2002 | 20 | 31 |
| 2003 | 25 | 37 |
| 2004 | 17 | 20 |
| 2005 | 9 | 18 |
| 2006 | 15 | 17 |
| 2007 | 10 | 10 |
| 2008 | 11 | 18 |
| 2009 | 7 | 17 |
| 2010 | 13 | 15 |
| 2011 | 10 | 17 |
| 2012 | 10 | 15 |
| 2013 | 3 | 17 |
| 2014 | 20 | 16 |
| 2015 | 10 | 13 |
| 2016 | 8 | 9 |
| 2017 | 13 | 21 |
| 2018 | 14 | 9 |
| 2019 | 14 | 20 |
| 2020 | 12 | 24 |
| 2021 | 11 | 20 |
| 2022 | 18 | 24 |
| 2023 | 7 | 21 |
| 2024 | 14 | 29 |
| 2025 | 12 | 25 |
| 2026 | 7 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof11 Aug 2026US 12,702,707 B2The Trustees of the University of Pennsylvania
- Recombinant herpes simplex virus for multiple targeting and use thereof19 May 2026US 12,629,399 B2Gencellmed Inc.
- Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same21 Apr 2026US 12,605,444 B2The Wistar Institute
- Herpesvirus with modified glycoprotein H for propagation in a cell21 Apr 2026US 12,606,801 B2Alma Matter Studiorum Universita Di Bologna
- Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions14 Apr 2026US 12,600,955 B1Sungkwang Medical Foundation
- Metabolic switches for anti-tumor immunity8 Oct 2026US 2026/0308516 A1Cold Spring Harbor Laboratory
- Rna for preventing or treating tuberculosis24 Sep 2026US 2026/0284168 A1
- Compositions for delivery of liver stage antigens and related methods3 Sep 2026US 2026/0256898 A1BioNTech SE
- Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput cloning27 Aug 2026US 2026/0250643 A1Albert Einstein College of Medicine
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector27 Aug 2026US 2026/0250709 A1Repli-Tech Co., Ltd.
Most cited
By later US patents
- Modified vaccinia virus298US 4,603,112 AHealth Research, Inc. · 1986
- Modified vaccinia virus and methods for making and using the same264US 4,769,330 AHealth Research, Inc. · 1988
- Method for immunizing animals with synthetically modified vaccinia virus240US 4,722,848 AHealth Research, Inc. · 1988
- Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters186US 5,464,758 A1995
- Methods for regulating gene expression170US 5,814,618 ABASF SE · 1998